Amphastar Pharma (AMPH) Tops Q1 EPS by 26c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $1.04, $0.26 better than the analyst estimate of $0.78. Revenue for the quarter came in at $171.8 million versus the consensus estimate of $176.36 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)